| 000 | nam a22 7a 4500 | ||
|---|---|---|---|
| 999 |
_c98909 _d98908 |
||
| 005 | 20191030114858.0 | ||
| 008 | 190228b ||||| |||| 00| 0 eng d | ||
| 020 | _a9783662496541 | ||
| 080 |
_a343.533:60 _bSHA/A |
||
| 100 | _aShaikh, Owais H. | ||
| 245 |
_aAccess to medicine versus test data exclusivity _bSafeguarding flexbilities under international law |
||
| 260 |
_bSpringer _aBerlin _c2016 |
||
| 300 | _axvi,256p. | ||
| 490 | _aMunich studies on innovation and competition 4 | ||
| 653 | _aDrug accessibility | ||
| 653 | _aGeneric drugs- Law and legislation | ||
| 653 | _aIntellectual property | ||
| 653 | _aComparative law | ||
| 942 | _cBK | ||